Sanguila, Siete Samarah M.
HRN: 25-94-38 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/27/2024
CEFUROXIME 750MG (VIAL)
09/27/2024
10/04/2024
IV
750mg
Q 8 Hours
T/C UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes